## **What is injection, immune globulin, (gamunex-c/gammaked)?**
HCPCS code J1561 refers to the injection immune globulin, specifically Gamunex-C or Gammaked, in a non-lyophilized (e.g., liquid) form, supplied in 500 mg doses. This medication is an immune globulin derived from human plasma and is intended for the treatment of immune deficiencies and certain autoimmune conditions. It can be administered through infusion or slow injection, depending on the patient’s needs and the provider’s clinical judgment.
The use of J1561 must align with medical necessity guidelines, ensuring that the therapy is prescribed for conditions where immune globulin has been proven to have benefits. This drug may be given alone or in addition to other services, and correct reporting under the assigned HCPCS code helps assist providers in maintaining accurate records and avoiding errors.
By following CMS guidance and payer-specific rules, clinicians can ensure compliant billing and safe, effective delivery of this critical treatment.
## **J1561 documentation requirements**
For HCPCS code J1561, records must support medical necessity and include the patient’s diagnosis, dosage (liquid 500 mg units), method of administration, and date of service. Documentation should confirm the intended treatment, record the patient’s response, and ensure that all information is complete and error-free to meet payer and CMS guidelines.
## **J1561 billing requirements**
When billing for HCPCS code J1561, providers should:
- Bill the correct date: Use J1561 for injection immune globulin (Gamunex- C/ Gammaked), non-lyophilized liquid 500 mg
- Support medical necessity: Ensure claims are backed by documentation showing the clinical reason for the treatment
- Include dosage and administration details: Report the total units, method of administration (injection or infusion), and date of service
- List of additional services separately: If other medications or procedures are provided in addition to J1561, bill them under their assigned codes.
- Follow CMS and payer guidance: Use the latest guidance and requirements to avoid errors or claim denials
- Ensure accuracy: Double-check claim forms to verify that the patient information, diagnosis codes, and service details are correct and complete
## **Other relevant codes**
- J1745 – Infliximab, 10 mg (reference product)
- J3490 – Unclassified drugs
Frequently asked questions
